No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / economics
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Developed Countries / classification
-
Developed Countries / economics
-
Drug Costs
-
Europe / epidemiology
-
Health Care Costs
-
Hematopoietic Stem Cell Transplantation / economics*
-
Hematopoietic Stem Cell Transplantation / statistics & numerical data
-
Humans
-
Imatinib Mesylate
-
Income
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / economics
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / epidemiology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
-
Piperazines / economics
-
Piperazines / therapeutic use
-
Pyrimidines / economics
-
Pyrimidines / therapeutic use
-
Societies, Medical / statistics & numerical data
-
Transplantation, Homologous / economics
-
Transplantation, Homologous / statistics & numerical data
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate